ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,411,000 | +84.4% | 30,440 | -3.1% | 0.16% | +79.5% |
| Q1 2019 | $765,000 | +66.3% | 31,400 | -2.8% | 0.09% | +46.7% |
| Q4 2018 | $460,000 | -6.3% | 32,300 | 0.0% | 0.06% | +13.2% |
| Q3 2018 | $491,000 | -9.4% | 32,300 | 0.0% | 0.05% | -15.9% |
| Q2 2018 | $542,000 | +6.1% | 32,300 | +3.0% | 0.06% | +3.3% |
| Q1 2018 | $511,000 | +20.8% | 31,350 | -5.0% | 0.06% | +17.3% |
| Q4 2017 | $423,000 | +2.4% | 33,000 | -1.8% | 0.05% | -1.9% |
| Q3 2017 | $413,000 | +47.0% | 33,600 | 0.0% | 0.05% | +39.5% |
| Q2 2017 | $281,000 | -11.9% | 33,600 | -5.9% | 0.04% | -15.6% |
| Q1 2017 | $319,000 | +1.9% | 35,700 | 0.0% | 0.04% | -6.2% |
| Q4 2016 | $313,000 | +29.9% | 35,700 | 0.0% | 0.05% | +26.3% |
| Q3 2016 | $241,000 | +88.3% | 35,700 | 0.0% | 0.04% | +72.7% |
| Q2 2016 | $128,000 | +21.9% | 35,700 | 0.0% | 0.02% | +22.2% |
| Q1 2016 | $105,000 | -30.5% | 35,700 | 0.0% | 0.02% | -33.3% |
| Q4 2015 | $151,000 | -7.4% | 35,700 | 0.0% | 0.03% | -12.9% |
| Q3 2015 | $163,000 | -36.8% | 35,700 | 0.0% | 0.03% | -31.1% |
| Q2 2015 | $258,000 | -1.9% | 35,700 | 0.0% | 0.04% | -2.2% |
| Q1 2015 | $263,000 | +52.9% | 35,700 | -2.2% | 0.05% | +48.4% |
| Q4 2014 | $172,000 | +31.3% | 36,500 | 0.0% | 0.03% | +29.2% |
| Q3 2014 | $131,000 | -21.6% | 36,500 | 0.0% | 0.02% | -22.6% |
| Q2 2014 | $167,000 | -2.9% | 36,500 | 0.0% | 0.03% | -11.4% |
| Q1 2014 | $172,000 | -6.0% | 36,500 | 0.0% | 0.04% | -2.8% |
| Q4 2013 | $183,000 | -19.4% | 36,500 | 0.0% | 0.04% | -28.0% |
| Q3 2013 | $227,000 | +36.7% | 36,500 | 0.0% | 0.05% | +25.0% |
| Q2 2013 | $166,000 | – | 36,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,850,650 | $75,330,000 | 5.64% |
| BVF INC/IL | 6,682,711 | $28,201,000 | 4.81% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,729,361 | $36,838,000 | 1.49% |
| First Light Asset Management, LLC | 530,391 | $2,238,000 | 0.94% |
| KOPP INVESTMENT ADVISORS LLC | 376,477 | $1,589,000 | 0.78% |
| Sarissa Capital Management LP | 700,000 | $2,954,000 | 0.57% |
| Orbimed Advisors | 10,689,000 | $45,108,000 | 0.41% |
| Bedell Frazier Investment Counselling, LLC | 178,971 | $755,000 | 0.37% |
| PINNACLE ASSOCIATES LTD | 3,453,487 | $14,574,000 | 0.31% |
| Artal Group S.A. | 3,710,000 | $15,656,000 | 0.29% |